
New: Springer book series from the Breast Cancer Research Foundation
13.08.2012 11:26
In collaboration with the Breast Cancer Research Foundation (BCRF), Springer is publishing a new book series entitled Advances in Experimental Medicine and Biology starting in 2013. The focus of these titles, which appear four times a year, is breast cancer research and all related aspects. The book series is intended to help advance understanding of research in this area.
The BCRF was founded in 1993 by the late Evelyn Lauder. The foundation significantly finances the further development of promising breast cancer therapies. The BCRF is responsible for the content and editing of the book series; Springer is responsible for production, marketing, sales and distribution. The books are available as eBooks on the Springer platform www.springerlink.com available and can be requested printed at any time in print-to-order (PTO) format.
The topic focus is primarily determined by Larry Norton and Clifford Hudis. Larry Norton is BCRF Scientific Director and Deputy Physician-in-Chief for Breast Cancer Programs and Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan-Kettering Cancer Center. Clifford Hudis is also a Doctor of Medicine and Chairman of the BCRF Scientific Advisory Committee and Chief of Breast Cancer Medicine Service at Memorial Sloan-Kettering.
“The number of outstanding breast cancer experts supported by the BCRF shows how complex this problem and our approaches to solving it are. We assume that this book series will not only reflect the state of current research, but will also provide other scientists with guidance and information for those affected with completely new creative approaches," says Dr. Norton.
Andrea Macaluso, Editorial Director Biomedicine at Springer: “We are very happy that the Breast Cancer Research Foundation has chosen Springer as its publishing partner. The BCRF has ensured that scientific research is perceived by the public. She has supported world-renowned scientists and clinicians through fellowships. We are delighted to be able to collaborate on the development of scientific publications that highlight BCRF’s remarkable work in breast cancer research.”
Advances in Experimental Medicine and Biology (http://www.springer.com/series/5584)
